Clinical Trials Directory

Trials / Completed

CompletedNCT05883891

Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.

Status
Completed
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Alcoholic hepatitis (AH) is the most severe form of acute alcohol-related liver disease. Maddrey's discriminant function (mDF) \>32 defines the severe form of AH, which is associated with a high mortality. Corticosteroid therapy (CS) represents the main medical treatment that may reduce short-term mortality. Lille score at day 7 assesses the therapeutic response to steroid therapy. At present, no parameters able to predict the response to steroid therapy have been highlighted. The mDF depends mainly on prothrombin time (PT). Aim of the present study was to evaluate if the PT value could predict the response to CS in severe AH (sAH).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTprothrombin timeProthrombin time at value at diagnosis was used to assess the presence of a correlation with Lille score at day 7 and therefore wether it could predict response to medical treatment.

Timeline

Start date
2017-06-01
Primary completion
2022-09-30
Completion
2022-11-30
First posted
2023-06-01
Last updated
2023-06-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05883891. Inclusion in this directory is not an endorsement.

Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis. (NCT05883891) · Clinical Trials Directory